Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Indiva Ltd V.NDVA

Alternate Symbol(s):  NDVAF

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of... see more

TSXV:NDVA - Post Discussion

Indiva Ltd > Breaking News Health canada
View:
Post by Duster340 on Sep 22, 2022 10:01am

Breaking News Health canada

to launch 18 month canabis review begins today. with the whole industry on life support regulatotry changes likely to happen, including taxes.)

Still no timeline for launch of Canada’s overdue Cannabis Act review

Image of Parliament Hill, Ottawa, Ontario, Canada

The Canadian government still has no publicly projected launch date for its mandatory review of the country’s 2018 recreational cannabis legalization law, more than eight months after the reappraisal was due to begin.

The delayed review is holding back progress toward much-needed regulatory reforms for Canada’s legal cannabis industry, according to one industry executive.

“There’s a lot that needs to be done with the legislative review,” Rick Savone, senior vice president of global government relations at Alberta-based Aurora Cannabis and chair of the industry group Cannabis Council of Canada, told MJBizDaily.

“And because that’s being held up, very little is getting done from a regulatory or from a legislative perspective.”

The review, which will result in a report to parliament, was supposed to begin by October 2021, three years after Canada legalized recreational cannabis.

However, MJBizDaily reported in February that the review had not yet begun.

Four months later, Health Canada still will not provide MJBizDaily with a timeline for when the review would begin.

A Health Canada spokesperson reiterated the federal department’s previous statement, describing the upcoming review as a “credible, evidence-driven process.

“Preparations are underway for the launch of the legislative review,” the spokesperson said via email.

In the meantime, Canada’s legal cannabis industry is waiting for the review to get underway – and even once it starts, it could last as long as 18 months, according to the 2018 cannabis legislation.

“All of the players are waiting to see what happens with the statutory review to be able to make the improvements that are required. I think there’s almost a consensus about what needs to be done for the sector,” Aurora’s Savone said.

“So we’re stuck waiting. And every day we wait, our competitors, especially our global competitors, get better positioned in this market.”

Canadian cannabis industry players previously told MJBizDaily that they want to use the review as a forum to address issues including:

  • Marketing and advertising restrictions.
  • Cannabis edibles potency limits.
  • Government regulatory fees.
  • Cannabis excise taxes.

Industry insiders say they plan to address several of the same issues through an upcoming cannabis roundtable that will bring together government officials and industry leaders.

 

Meanwhile, the Canadian federal government’s recently updated Forward Regulatory Plan for 2022 through 2024 lays out several regulatory changes for the country’s cannabis industry that “Health Canada aims to propose or finalize in the next 2 years,” all of which have been previously announced.

Those potential regulatory changes include:

Changes to cannabis beverage possession limits will not be ready before this fall, according to Health Canada.

Comment by Bronson123 on Sep 22, 2022 11:15am
Higher doses edibles will be a game changer 
Comment by Stuboo on Sep 23, 2022 5:02pm
The game changer is the looming recession that nobody will admit is coming. Which companies make it through it and not run out of cash will be the winners.
Comment by QCINDIVALUVIN on Sep 23, 2022 7:53pm
Cash flow positive companies with no big debts and burn like ndva should come out on top.
Comment by Duster340 on Sep 24, 2022 9:40pm
The looming recession could be a blessing in disguise, now with higher interest rates and an economic slow down on the horizon, it will be just another nail in the coffin for some of those already struggling small mom and pop stores that are collectively eating into NDVA's  market share. they may have to permanently close there doors. and then NDVA will come out the other side 1.5 to 2 ...more